20 septembre 2023 | International, Terrestre
Leidos wins $7.9 billion US Army information technology contract
The Department of Defense received three bids for the Common Hardware Systems 6th Generation contract, records show.
6 août 2020 | International, Aérospatial, Naval, Terrestre, C4ISR, Sécurité
Contract Awards by US Department of Defense - August 05, 2020
AIR FORCE
HHI Corp., Ogden, Utah (FA2517-20-D-0011); Pro-Mark Services, Inc., West Fargo, North Dakota (FA2517-20-D-0010); Native American Services Corp., Kellogg, Idaho (FA2517-20-D-0009); and Creative Times Dayschool LLC, Ogden, Utah (FA2517-20-D-0007), have collectively been awarded contracts valued at $422,222,224 in support of an indefinite-delivery/indefinite-quantity, multiple-award construction contract. This contract provides for a broad range of design-bid-build/design-build services up to 100% and maintenance, repair and minor construction work on real property along the Front Range of Colorado and Wyoming. Work will be primarily performed at Fort Carson Army Base, Colorado, to include Pinon Canyon Maneuver Site, and Pueblo Chemical Depot; Cheyenne Mountain Air Force Station, Colorado; Peterson Air Force Base, Colorado; Schriever AFB, Colorado; United States Air Force Academy, Colorado, to include Farish Memorial Recreation and Bulls Eye Auxiliary Airfield; Buckley AFB, Colorado; and F.E. Warren AFB, Wyoming. Work is expected to be completed Feb. 2, 2028. This award is the result of a competitive acquisition and 32 offers were received. Fiscal 2020 operations and maintenance funds in the amount of $5,000 will be awarded to each contractor at the time of award. The 21st Contracting Squadron Peterson AFB, Colorado, is the contracting activity.
DEFENSE LOGISTICS AGENCY
Chico Produce Inc.,* doing business as ProPacific Fresh, Durham, California (SPE300-20-D-P351, $135,000,000), and Coast Citrus Distributors,* doing business as Coast Tropical, Union City, California (SPE300-20-D-S742, $15,000,000) have each been awarded a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract under solicitation SPE300-19-R-0006 for fresh fruit and vegetable support for the Northern California and Northwestern Nevada zones. These were competitive acquisitions with two responses received. They are five-year contracts with no option periods. Locations of performance are California and Nevada, with an Aug. 5, 2025, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps, Coast Guard, Department of Agriculture schools and tribal reservations. Type of appropriation is fiscal 2020 through 2025 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
NAVY
General Dynamics National Steel and Shipbuilding Co. – Norfolk, Norfolk, Virginia, is awarded a $106,923,080, firm-fixed-price contract for the execution of the USS Bataan (LHD 5) fiscal 2020 selected restricted availability. This availability will include a combination of maintenance, modernization and repair of the USS Bataan (LHD 5). This contract includes options which, if exercised, will bring the cumulative value of this contract to $130,861,394. Work will be performed in Norfolk, Virginia. This is a “long-term” non-docking availability and was solicited on a coast-wide (east and Gulf coasts) basis without limiting the place of performance to the vessel's homeport. General Dynamics NASSCO – Norfolk will provide the facilities and human resources capable of completing, coordinating and integrating multiple areas of ship maintenance, repair and modernization for USS Bataan (LHD 5). Work is expected to be completed by December 2021. Fiscal 2020 operations and maintenance (Navy); and 2020 other procurement (Navy) funding in the amount of $106,923,080 will be obligated upon contract award and funds in the amount of $1,816,383 will expire at the end of the current fiscal year. This contract was competitively procured using full and open competition via the Federal Business Opportunities website and one offer was received in response to Solicitation No. N00024-19-R-4467. The Naval Sea Systems Command, Washington, D.C., is the contracting activity (N00024-20-C-4467).
Kellogg Brown and Root Services Inc., Houston, Texas, is awarded a $75,000,000 maximum amount, firm-fixed-price, indefinite-delivery/indefinite-quantity job order contract for construction projects at Camp Lemonnier and Chabelley Air Field, Djibouti. No task orders are being issued at this time. Work will be performed in Djibouti, Africa. The work to be performed provides for various renovations, repairs, maintenance, replacements, alterations, demolition and construction projects for Camp Lemonnier and Chabelley Air Field, Djibouti. The construction may include minor alteration, repair of real property (industrial and commercial) and utilities. The term of the contract is not to exceed 60 months and work is expected to be completed by September 2025. Fiscal 2020 military operations and maintenance (Navy) (O&M, N) contract funds in the amount of $5,000 are obligated on this award for the guaranteed minimum and will expire at the end of the current fiscal year. Future task orders will be primarily funded by O&M, N and military construction (Navy). This contract was competitively procured via the Federal Business Opportunities website and six proposals were received. The Naval Facilities Engineering Command, Europe Africa Central, is the contracting activity (N33191-20-D-0811).
General Dynamics National Steel and Shipbuilding Co. San Diego, San Diego, California, was awarded a $37,195,489, firm-fixed-price contract for the execution of the USS Lake Erie (CG 70) fiscal 2021 Selected Restricted Availability. This availability will include a combination of maintenance, modernization and repair of the USS Lake Erie. This contract includes a base period and options which, if exercised, will bring the cumulative value of this contract to $62,991,030. Work will be performed in San Diego, California. This is a “long-term” availability and was solicited on a coast-wide (west coast) basis without limiting the place of performance to the vessel's homeport. National Steel and Shipbuilding Co. will provide the facilities and human resources capable of completing, coordinating and integrating multiple areas of ship maintenance, repair and modernization for USS Lake Erie. Work is expected to be completed by January 2022. Fiscal 2020 other procurement (Navy); and 2020 operations and maintenance (Navy) funding in the amount of $37,195,489 will be obligated at time of award and funds in the amount of $3,633,807 will expire at the end of the current fiscal year. This contract was competitively procured using full and open competition via the Federal Business Opportunities website and three offers were received in response to Solicitation No. N00024-20-R-4401. The Naval Sea Systems Command, Washington, D.C., is the contracting activity. (Awarded July 31, 2020)
ARMY
Leidos Inc., Reston, Virginia, was awarded an $11,916,585 modification (P00001) to contract W58RGZ-20-C-0024 to support the continued system operations and sustainment services and test and training services in support of the Saturn Arch Aerial Intelligence Systems Quick Reaction Capability Program. Work will be performed in Reston, Virginia; Bridgewater, Virginia; and Huntsville, Alabama, with an estimated completion date of March 16, 2024. Fiscal 2020 operations and maintenance (Army) funds in the amount of $11,916,585 were obligated at the time of the award. U.S. Army Contracting Command, Redstone Arsenal, Alabama, is the contracting activity.
DR Reed and Associates Inc.,* Nederland, Colorado, was awarded a $9,800,000 firm-fixed-price contract for architecture and engineering services for civil works projects at various locations in the Los Angeles District. Bids were solicited via the internet with five received. Work locations and funding will be determined with each order, with an estimated completion date of Aug. 4, 2025. U.S. Army Corps of Engineers, Los Angeles, California, is the contracting activity (W912PL-20-D-0032).
CORRECTION: It was previously-announced that contract W911QY-20-C-0086 had been awarded on Aug. 3, 2020. The actual award date was Aug. 4, 2020.
*Small Business
https://www.defense.gov/Newsroom/Contracts/Contract/Article/2302143/source/GovDelivery/
Sur le même sujet
-
-
20 mars 2023 | International, Terrestre
Croatian lawmakers back new armored vehicles, Spike anti-tank missiles
The country wants new vehicles and weapons to meet capability targets pledged to NATO.
-
30 novembre 2018 | International,
Reinventing Drug Discovery and Development for Military Needs
Flying at 50,000 feet, diving deep in the ocean, or hiking for miles with gear through extreme climates, military service members face conditions that place unique burdens on their individual physiology. The potential exists to develop pharmacological interventions to help service members complete their toughest missions more safely and efficiently, and then recover more quickly and without adverse effects, but those interventions must work on complex physiological systems in the human body. They will not be realized under the prevailing system of drug discovery and development with its focus on engaging single molecular targets. DARPA created the Panacea program to pursue the means of rapidly discovering, designing, and validating new, multi-target drugs that work with the body's complexity to better support the physiological resilience and recovery of military service members. The premise of Panacea is that the physiological systems of the human body work in complex and highly integrated ways. Drugs exert effects on our bodies by physically interacting with and changing the functional state of biomolecules that govern the functions of cells and tissues. Most drugs target proteins, which are the principle cellular workhorses. Ideally, drugs would target multiple proteins simultaneously to exert precise, network-level effects. One major problem facing the drug development community is that the functional proteome — the complete collection of proteins and their roles in signaling networks — is largely dark to science. Despite being able to identify many of the proteins within a cell, researchers do not have a firm grasp on everything those proteins do and how they interact to affect physiology. Due to this sparsity of structural and functional knowledge, the state of the art in drug development — what Panacea seeks to transform — is to engage only a very small fraction of known protein targets to achieve an effect. In fact, today's approach to drug design singles out individual proteins in certain cells. That hyper-specificity is an attempt to minimize the risk of side effects and speed time to market, but it also yields a thin stream of drugs, many of which have similar mechanisms and relatively muted effectiveness compared to what might be achieved using a multi-target, systems-based approach. “The current roster of drugs approved by the U.S. Food and Drug Administration only targets about 549 proteins, yet the body can produce more than six million different protein variants,” said Tristan McClure-Begley, the Panacea program manager. “The opportunity space for pharmacological intervention is vast and effectively untapped, but to access it we need new technology for understanding and targeting the human functional proteome.” Panacea will address the lack of functional knowledge about the proteome. DARPA's call to the research community is to consider complex physiological conditions relevant to military service members — for instance, metabolic stress during extreme endurance missions or pain and inflammation after injury; investigate the molecular mechanisms underlying those conditions; identify multiple, key molecular targets involved; and develop novel medicinal chemistry approaches to synthesize interventions that modulate those targets. DARPA believes that multi-target drugs will deliver safer and more efficacious solutions to military requirements for readiness and recovery over state-of-the-art interventions. “Many of the most successful drugs produced in the past were found rather than made, and we knew what they did long before we knew how they did it,” McClure-Begley said. “To deliver improved interventions, we need to get to a place where we can investigate all of the potential proteins at play for a given condition and then prioritize sets of protein targets and signaling networks to effectively modulate physiological systems, regardless of what prior knowledge exists about those targets.” The Panacea program aims to generate initial proof of concept for this new direction in drug discovery and development. Research will primarily involve animal models, human cell derived organoids, and high-throughput cell culture models. However, to support eventual transition to humans, DARPA will work with federal agencies to develop a regulatory pathway for future medical use. By the end of the five-year program, DARPA will require teams to submit novel drug candidates to the U.S. Food and Drug Administration for review as an Investigational New Drug or for Compassionate Use. DARPA will hold a Proposers Day on December 14, 2018, in Arlington, Virginia, to provide more information about Panacea and answer questions from potential proposers. For details of the event, including registration requirements, visit https://go.usa.gov/xP6hD. A forthcoming Broad Agency Announcement will fully describe the program structure and objectives. https://www.darpa.mil/news-events/2018-11-28